Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Chang Liu

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
The American Journal of Chinese Medicine|May 18, 2019
Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF- <math></math> B Signaling PathwayFei-Ting Hsu, I-Tsang Chiang, Yu-Cheng Kuo, et al.
BMC Geriatrics|November 1, 2023
Association between chronic pain and acute coronary syndrome in the older population: a nationwide population-based cohort studyYu-Chang Liu, Chung-Han Ho, Yi-Chen Chen, et al.
In Vivo (Athens, Greece)|April 30, 2024
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse ModelJr-DI Yang, Yu-Chang Liu, Hsiao-Chia Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2019
Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivoMao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, et al.
Molecular Medicine (Cambridge, Mass.)|February 17, 2026
Fluoxetine suppresses triple-negative breast cancer progression by inducing apoptosis, inhibiting Src-mediated invasiveness, and enhancing anti-tumor immunityHsing-Ju Wu, Yueh-Shan Weng, Yu-Chang Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 21, 2019
Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032]Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, et al.
Journal of Cellular and Molecular Medicine|August 20, 2025
Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targeting the EGFR/NF-κB Pathway and Immune ModulationYu-Chang Liu, Chih-Ying Liao, Fei-Ting Hsu, et al.
International Journal of Oncology|May 9, 2014
Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signalingFei-Ting Hsu, Yu-Chang Liu, I-Tsang Chiang, et al.
Bioscience Reports|March 15, 2018
Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing miceMao-Chi Weng, Mei-Hui Wang, Jai-Jen Tsai, et al.
Molecular Medicine (Cambridge, Mass.)|July 3, 2026
Cardiac extracellular vesicle proteomics identifies mitochondrial and contractile dysfunction in carbon monoxide poisoning and their reversal by hyperbaric oxygen therapyChien-Wei Hsiung, Yu-Chang Liu, Tzu-Hao Chen, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
The American Journal of Chinese Medicine|May 18, 2019
Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF- <math></math> B Signaling PathwayFei-Ting Hsu, I-Tsang Chiang, Yu-Cheng Kuo, et al.
BMC Geriatrics|November 1, 2023
Association between chronic pain and acute coronary syndrome in the older population: a nationwide population-based cohort studyYu-Chang Liu, Chung-Han Ho, Yi-Chen Chen, et al.
In Vivo (Athens, Greece)|April 30, 2024
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse ModelJr-DI Yang, Yu-Chang Liu, Hsiao-Chia Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2019
Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivoMao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, et al.
Molecular Medicine (Cambridge, Mass.)|February 17, 2026
Fluoxetine suppresses triple-negative breast cancer progression by inducing apoptosis, inhibiting Src-mediated invasiveness, and enhancing anti-tumor immunityHsing-Ju Wu, Yueh-Shan Weng, Yu-Chang Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 21, 2019
Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032]Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, et al.
Journal of Cellular and Molecular Medicine|August 20, 2025
Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targeting the EGFR/NF-κB Pathway and Immune ModulationYu-Chang Liu, Chih-Ying Liao, Fei-Ting Hsu, et al.
International Journal of Oncology|May 9, 2014
Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signalingFei-Ting Hsu, Yu-Chang Liu, I-Tsang Chiang, et al.
Bioscience Reports|March 15, 2018
Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing miceMao-Chi Weng, Mei-Hui Wang, Jai-Jen Tsai, et al.
Molecular Medicine (Cambridge, Mass.)|July 3, 2026
Cardiac extracellular vesicle proteomics identifies mitochondrial and contractile dysfunction in carbon monoxide poisoning and their reversal by hyperbaric oxygen therapyChien-Wei Hsiung, Yu-Chang Liu, Tzu-Hao Chen, et al.
Pageof 10